suggested squamous cell carcinoma, anti‐PD‐1 plus anti‐CTLA‐4 regimens, and NLR <3 as potential predictive factors for irAEs during chemoimmunotherapy induction with platinum agents in patients with NSCLC.20 Here, CTLA4 is linked to non-small cell lung carcinoma.